Akebia Therapeutics, Inc.: BTIG from long to neutral on the stock








Marketzone with MT Newswires 2022

All the news about AKEBIA THERAPEUTICS, INC.

Analyst Recommendations on AKEBIA THERAPEUTICS, INC.

2022 turnover 199M

178M
2022 net result -155M

-139M
Net debt 2022 49.8M

44.6M
PER 2022-1.01x
2022 return
Capitalization 150M
150M
135M
VE / CA 20221.01x
VE / CA 20231.00x
Number of employees426
Floating98.8%

Chart AKEBIA THERAPEUTICS, INC.


Tough :

Period:




Akebia Therapeutics, Inc. : Chart technical analysis Akebia Therapeutics, Inc. |  Market area

Trends Technical Analysis AKEBIA THERAPEUTICS, INC.

Short termMiddle termLong term
TrendsBearishBearishBearish

Evolution of the Income Statement

Sale

Purchase

Average recommendationSAVE
Number of Analysts7
Last Closing Price$0.83
Average price target$1.75
Deviation / Average Target111%

Officers and Directors




Source link -88